Demographic, clinical, and disease characteristics of patients with atrial fibrillation on edoxaban therapy according to the bleeding risk: A report from evaluation of treatment safety in patients with atrial fibrillation on edoxaban therapy in real

被引：0
|
作者：
Avci, Eyup [1 ]
Akgun, Didar Elif [2 ]
Arslan, Ugur [3 ]
Inci, Sinan [4 ]
Yildirim, Ozge Turgay [5 ]
Yenercag, Mustafa [6 ]
Kasap, Mithat [7 ]
Turk, Ugur Onsel [8 ]
机构：
[1] Balikesir Univ, Dept Cardiol, Fac Med, Balikesir, Turkey
[2] Kirklareli Training & Res Hosp, Dept Cardiol, Kirklareli, Turkey
[3] Samsun Training & Res Hosp, Dept Cardiol, Samsun, Turkey
[4] Aksaray Univ Training & Res Hosp, Dept Cardiol, Aksaray, Turkey
[5] Eskisehir City Hosp, Eskisehir, Turkey
[6] Ordu Univ, Dept Cardiol, Fac Med, Ordu, Turkey
[7] Daiichi Sankyo Turkey, Istanbul, Turkey
[8] Izmir Econ Univ, Dept Cardiol, Fac Med, Izmir, Turkey
来源：
ANATOLIAN JOURNAL OF CARDIOLOGY | 2022年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP-084
引用
收藏
页码：S101 / S103
页数：3
相关论文
共 50 条
  • [31] Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study)
    Frisullo, Giovanni
    Profice, Paolo
    Brunetti, Valerio
    Scala, Irene
    Bellavia, Simone
    Broccolini, Aldobrando
    Caliandro, Pietro
    Di Iorio, Riccardo
    Morosetti, Roberta
    Pilato, Fabio
    Laborante, Renzo
    Della Marca, Giacomo
    BRAIN SCIENCES, 2021, 11 (01) : 1 - 8
  • [32] PROSPECTIVE OBSERVATIONAL STUDY OF SAFETY OF EARLY TREATMENT WITH EDOXABAN IN PATIENTS WITH ISCHEMIC STROKE AND ATRIAL FIBRILLATION (SATES STUDY)
    Frisullo, G.
    Profice, P.
    Della Marca, G.
    Broccolini, A.
    Laborante, R.
    Brunetti, V.
    Scala, I.
    Marotta, J.
    Morosetti, R.
    Caliandro, P.
    Di Iorio, R.
    Piano, C.
    Pilato, F.
    Monforte, M.
    Bellavia, S.
    Calabresi, P.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 149 - 149
  • [33] Prospective observational study of safety of early treatment with Edoxaban in patients with ischemic stroke and atrial fibrillation (SATES STUDY)
    Frisullo, G.
    Profice, P.
    Laborante, R.
    Della Marca, G.
    Broccolini, A.
    Brunetti, V.
    Pilato, F.
    Morosetti, R.
    Marotta, J.
    Scala, I.
    Bellavia, S.
    Calabresi, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 22 - 22
  • [34] Distribution of Anti-Factor Xa Activity in Patients on Edoxaban Therapy for Non-Valvular Atrial Fibrillation
    Osanai, Hiroyuki
    Ajioka, Masayoshi
    Masutomi, Tomohiro
    Kuwayama, Tasuku
    Ishihama, Sota
    Takahashi, Maki
    Kanbara, Takahiro
    Inoue, Yosuke
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    CIRCULATION JOURNAL, 2016, 80 (03) : 745 - 747
  • [35] Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program
    Diemberger, I.
    Chen, C.
    Choi, J.
    De Groot, J.
    Kirchhof, P.
    Pecen, L.
    Unverdorben, M.
    Wang, C.
    Yamashita, T.
    De Caterina, R.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [36] CASE REPORT: EFFICACY AND SAFETY OF EDOXABAN IN ELDERLY PATIENT WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE
    Carbone, S.
    Capasso, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G142 - G142
  • [37] Real-World Risk of Thromboembolism or Bleeding with Warfarin or Dabigatran Therapy in Patients with Atrial Fibrillation
    Charland, Scott I.
    Malone, Daniel C.
    Agatep, Barnabie C.
    Herrera, Vivian
    Hawk, Gosia S.
    Schrader, Bruce J.
    Stanek, Eric J.
    CIRCULATION, 2012, 126 (21)
  • [38] Effectiveness and safety of edoxaban and warfarin in nonvalvular atrial fibrillation patients: A meta-analysis of real-world studies
    Alsultan, Mohammed M.
    Guo, Jeff J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 208 - 208
  • [39] Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
    Dzeshka, Mikhail S.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2661 - 2678
  • [40] Edoxaban Treatment in routiNe clinical prActice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe): Baseline characteristics of the Austrian patients
    Weiss, Thomas
    Gwechenberger, Marianne
    Auer, Johann
    Kaulfersch, Carl
    Kober, Alexander
    Siostrzonek, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 385 - 385
12345